Biohaven Ltd., a biopharmaceutical company, focuses on the discovery, development, and commercialization of treatments for immunology, neuroscience, and oncology therapeutic areas worldwide. It develops BHV-1300, which is in Phase 2 clinica...
Q1 2026
May 4, 2026
FY 2025
Mar 2, 2026
Q4 2025
Q3 2025
Nov 10, 2025
Q2 2025
Aug 11, 2025
